Programmed death-ligand 1 expression on CD22-specific chimeric antigen receptor-modified T cells weakens antitumor potential

Liu, J; Zhang, FJ; Yu, J; Zhao, Q

Zhao, Q (通讯作者)，Univ Macau, Fac Hlth Sci, Canc Ctr, Taipa 999078, Macau Spr, Peoples R China.;Yu, J (通讯作者)，Beihang Univ, Sch Engn Med, Beijing 100083, Peoples R China.

MEDCOMM, 2022; 3 (2):

Abstract

The molecules of programmed cell death protein-1 (PD-1) and ligand-1 (PD-L1) become new therapeutic targets for cancer therapy. Although tumor-express......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索